BORZOMED Injection 3.5mg

Borzomed 3.5mg Injection is utilized for treating multiple myeloma and mantle-cell lymphoma. It functions by inhibiting or slowing the proliferation of cancer cells.

Borzomed 3.5mg Injection is administered via injection by a qualified healthcare professional. Your physician will determine the appropriate dosage and frequency based on your specific treatment needs, which may vary over time. It is crucial to follow your doctor’s instructions precisely. Incorrect usage or excessive dosage can lead to severe side effects. While it may take several weeks or months for you to notice or experience the benefits, do not discontinue use unless directed by your physician.

Common side effects of this medication include fatigue, nausea, vomiting, and decreased appetite. You may be advised to maintain adequate hydration throughout your treatment. Avoid driving or operating heavy machinery, as this medication may induce fatigue and dizziness. Additionally, this medicine may lower blood cell counts (reducing both red and white blood cells), which can increase the risk of infections. Regular blood tests are necessary to monitor your blood cell levels, as well as your heart, liver, and uric acid levels.

Prior to receiving Borzomed 3.5mg Injection, consult your doctor if you have any history of liver, kidney, or heart disease, or any bleeding disorders. It is essential to seek medical advice if you experience symptoms such as memory loss or cognitive difficulties. Numerous other medications may interact with this treatment, so inform your healthcare team of all drugs you are currently taking. This medication is not advised during pregnancy or while breastfeeding. Both males and females should use effective contraception during treatment to prevent pregnancy.